These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9100077)
21. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)]. Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915 [TBL] [Abstract][Full Text] [Related]
22. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353 [TBL] [Abstract][Full Text] [Related]
23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution]. Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040 [TBL] [Abstract][Full Text] [Related]
24. [Prevalence of bacterial pathogens and antimicrobial susceptibility: a multicenter study in Akita prefecture]. Kitabayashi A; Miura AB; Miura K; Abo S; Hatakeyama Y Kansenshogaku Zasshi; 1993 Sep; 67(9):795-807. PubMed ID: 8409592 [TBL] [Abstract][Full Text] [Related]
25. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility]. Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguchi O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M Jpn J Antibiot; 2006 Aug; 59(4):217-315. PubMed ID: 17111595 [TBL] [Abstract][Full Text] [Related]
26. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000]. Nakasone I; Onaga S; Fukunaga H; Saitoh H; Yamane N; Sato Y Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533 [TBL] [Abstract][Full Text] [Related]
27. [Susceptibilities of clinical bacterial isolates to antimicrobial agents, 1989. A study mainly focused on imipenem. The Research Group for Testing Imipenem Susceptibilities of Clinical Isolates]. Igari J Jpn J Antibiot; 1991 Dec; 44(12):1329-40. PubMed ID: 1798067 [TBL] [Abstract][Full Text] [Related]
28. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862 [TBL] [Abstract][Full Text] [Related]
30. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)]. Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637 [TBL] [Abstract][Full Text] [Related]
31. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [TBL] [Abstract][Full Text] [Related]
32. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076 [TBL] [Abstract][Full Text] [Related]
33. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322 [TBL] [Abstract][Full Text] [Related]
34. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics]. Miyazakin S; Yamaguchi K Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536 [No Abstract] [Full Text] [Related]
35. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents]. Igari J; Watanabe N; Uehara N; Inoue M; Yoshida H; Imafuku Y; Nishino T; Shibano T; Satou S; Kobayashi I; Takahashi A; Yomoda S; Matsuoka K; Oguri T; Ohba Y; Kumasaka K; Tokuda K; Kobayashi Y; Hongo T; Okada J; Sasaki T; Matsumoto N; Hirata Y; Nakasaki N; Ono J; Takata T; Kawaguchi R; Ohtaki Y; Kajimura K; Ishigo S; Hashimoto T; Aoki N; Okamoto E; Murakami E; Saeki H Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147 [TBL] [Abstract][Full Text] [Related]
36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). III Secular changes in susceptibility]. Ogiwara M; Ishibashi K; Yoshida H; Imafuku Y; Murai M; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Watanabe K; Kobayashi Y; Uchida H; Ooe H; Nishikawa M; Matsuda S; Fujime M; Fujita K; Oka T; Takano Y; Miyagawa Y; Furuhama T; Kohno S; Hirakata Y; Mochida C Jpn J Antibiot; 1999 Mar; 52(3):177-267. PubMed ID: 10367263 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study. Asbell PA; Sanfilippo CM; Pillar CM; DeCory HH; Sahm DF; Morris TW JAMA Ophthalmol; 2015 Dec; 133(12):1445-54. PubMed ID: 26502312 [TBL] [Abstract][Full Text] [Related]
38. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902 [TBL] [Abstract][Full Text] [Related]
39. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)]. Shimada K; Nakano K; Igari J; Oguri T; Ikemoto H; Mori T; Yokouchi H; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Okada S; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Nakata K; Nakatani T; Inagawa H; Kudo K; Kobayashi N; Tanaka T; Kobayashi H; Goto H; Kawai S; Takeda H; Sumitomo M; Matsushima T; Niki Y; Kohno S; Miyazaki Y; Yanagihara K; Hirakata Y; Matsuda J; Nasu M; Hiramatsu K; Suga M; Tosaka M Jpn J Antibiot; 2004 Jun; 57(3):213-45. PubMed ID: 15376784 [TBL] [Abstract][Full Text] [Related]
40. [Recent trend of incidence of respiratory pathogenic bacteria and its susceptibility to antimicrobial agents: studies in the year 1984-1986]. Nishioka K; Ogiwara H; Ida S; Takishima T Jpn J Antibiot; 1988 Sep; 41(9):1212-22. PubMed ID: 3149325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]